| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a95d0c63b9b3f2bc8e8d6b45fbe7789 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-04 |
| filingDate |
2008-05-23^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-03-22^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2425e614dd459dd79a4941f8cf14eddd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ede637400606754ae4b8805fd5a4ad2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f617f30fb0ee0020123e37b3290a657e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99b6bf6fc1ce0b82a4bda24eb638e008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3371454d0214e74fe0f16c663a8b1e0f |
| publicationDate |
2011-03-22^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7910332-B2 |
| titleOfInvention |
Method for manufacturing a recombinant polyclonal protein |
| abstract |
The invention relates to a method for manufacturing a recombinant polyclonal protein composition, in particular a recombinant polyclonal antibody composition. The method comprises obtaining a collection of cells transfected with a collection of variant nucleic acid sequences, wherein each cell in the collection is transfected with and capable of expressing one member of the collection, which encodes a distinct member of a polyclonal protein. The cells are cultured under suitable conditions for expression of the polyclonal protein, which is obtained from the cells or culture supernatant. The nucleic acid sequence is introduced into the cells by transfection with a collection of vectors. The present method is suitable for manufacturing recombinant polyclonal antibodies for therapeutic uses. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9447174-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9790269-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10502745-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018073393-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009136498-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011117605-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9163232-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9593327-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8617881-B2 |
| priorityDate |
2007-05-25^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |